Status:
COMPLETED
Tamoxifen Citrate Decision Aids for Women at Increased Risk of Breast Cancer
Lead Sponsor:
University of Michigan Rogel Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Eligibility:
FEMALE
Phase:
PHASE1
PHASE2
Brief Summary
RATIONALE: Evaluating a decision aid that describes the risks and benefits of taking tamoxifen citrate to prevent breast cancer may be helpful for women at increased risk of breast cancer. PURPOSE: T...
Detailed Description
OBJECTIVES: * To develop and test a decision aid for describing the risks and benefits of taking tamoxifen citrate to prevent primary breast cancer in women at increased risk of breast cancer. OUTLI...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Believed to be at increased risk of breast cancer (risk of ≥ 1.66% over 5 years) according to electronic-based medical data
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- Not specified
Exclusion
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
1683 Patients enrolled
Trial Details
Trial ID
NCT00967824
Start Date
October 1 2005
Last Update
March 24 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.